CT111CT26-hVEGFAK104PD-1VEGFsolid tumors
…D-1 and CTLA-4, suggesting that tumor-secreted VEGF may amplify CT111 activity within the TME. These findings support clinical develo…
4articles mentioning drugs
6drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: PD-1 ×
PD-1
This drug is selected. Its supporting articles are shown below.
Articles mentioning PD-1
4 articles · page 1 of 1pembrolizumabInfliximabipilimumabnivolumaboxaliplatincarboplatincapecitabineprednisolonePD-L1PD-1+4 more
… during treatment with PD-1 inhibitors. Eight patients received pembrolizumab (six as monotherapy and two in combination with carboplatin plu…
85.1%
PD-1solid tumorsbreast cancerhematological cancersChimeric antigen receptor (CAR)-T cell therapy
…and activation of tumor-infiltrating cytolytic CD8+T cells. The PD-1 checkpoint inhibitor further augmented the antitumor response a…
92.0%
PD-L1PD-1OX40therapeutic antibodiesTransCure bioServicesmelanoma
…estigational. These include immune checkpoint inhibitors (PD-1, PD-L1, OX40), bispecific T engagers (CD3xCD20 or CD3xEGFR), and tumor…